Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,746
Closed -$4M 232
2023
Q4
$4M Sell
8,746
-186
-2% -$91.7K 0.61% 45
2023
Q3
$4.35M Buy
8,932
+119
+1% +$55.9K 0.68% 41
2023
Q2
$3.94M Buy
8,813
+148
+2% +$74.5K 0.62% 39
2023
Q1
$4.21M Buy
+8,665
New +$4.28M 0.75% 37

Other funds holding HUM

Oxbow Advisors's HUM Position: Q1 2024 in Review

Oxbow Advisors sold out of Humana (HUM) in Q1 2024, closing a stake of 8,746 shares — an estimated $4M sold.

Oxbow Advisors first reported a position in HUM in Q1 2023 and held it in 4 quarters. The position peaked at $4.35M in Q3 2023. 1,029 funds tracked by Wall St. Rank hold HUM as of Q1 2024.

  • Oxbow Advisors reported no remaining Humana position as of Q1 2024 after selling out during the quarter.
  • Oxbow Advisors sold 8,746 Humana shares in Q1 2024, an estimated $4M.
  • Oxbow Advisors first reported a position in Humana in Q1 2023 and held it in 4 quarters.
  • Oxbow Advisors's Humana position peaked at $4.35M in Q3 2023.
  • 1,029 funds tracked by Wall St. Rank held Humana as of Q1 2024.

Based on Oxbow Advisors's 13F filing for Q1 2024, filed 6 May 2024.